<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01107002</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-Emb-006</org_study_id>
    <nct_id>NCT01107002</nct_id>
  </id_info>
  <brief_title>Comparison of 5 Day Embryo Transfer With 2-3 Day Transfer in Patients With Previous In Vitro Fertilization Failure</brief_title>
  <official_title>Comparison of 5 Day Embryo Transfer With 2-3 Day Transfer in Patients Who Failed to Conceive in Two or More Day 2-3 Embryo Transfer Cycle in Royan Institute</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether embryo transfer on day 3 versus day 5 shows
      a significant difference in implantation, clinical pregnancy, live birth, miscarriage and
      multiple pregnancy rates among women with at least two previous IVF failures
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 200 infertile women with at least two previous IVF failures will enroll in this
      prospective randomized clinical trial study and will randomly be divided into two groups.
      Random permuted blocks with a block size of 4 will be used to ensure randomization and
      complete allocation concealment.

      The study protocol will be assessed by an independent institutional review board and Royan
      ethics committee.

      Ovarian stimulation protocol will include the use of a GnRH agonist (Superfact; Aventis
      Pharma Deutshlan, Frankfurt, Germany) administered in the long (down-regulation) protocol and
      the subsequent addition of FSH (Gonal F, Sereno, Switzerland). Embryos will be initially
      cultured in G1.V5 medium) Vitrolife-Sweden)TM on day 1 and 2, being transferred from this
      medium to G2.V5 ) Vitrolife-Sweden)TM on day 3. Embryos will be transferred on day 5,
      depending on the degree of expansion of the blastocyst.

      Main outcome measures will be implantation, clinical pregnancy and live birth rates.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Pregnancy rate</measure>
    <time_frame>6-8 weeks after oocyte retrieval</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>After 37 weeks of gestational age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>4 weeks after embryo transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage rate</measure>
    <time_frame>18 weeks after fertilization</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Day 5 embryo transfer group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Embryo will transfer at blastocyst stage (day 5 after ovum pick up)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Day 5 embryo transfer group</intervention_name>
    <description>Embryo will transfer at blastocyst stage (day 5 after ovum pick up)</description>
    <arm_group_label>Day 5 embryo transfer group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age fewer than 40

          -  Normal uterine cavity and patent tubes by either hysterosalpingogram or laparoscopy
             and hysteroscopy

          -  Two previous or more failed IVF/ICSI cycles

        Exclusion Criteria:

          -  Women with submucous myoma

          -  Women with intra mural or subserous myoma greater than 3 cm

          -  Women with Endometriosis or Endometrioma

          -  Hydrosalpinx
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahnaz Ashrafi,, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royan Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <zip>19395-4644</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.royaninstitute.org</url>
  </link>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2010</study_first_submitted>
  <study_first_submitted_qc>April 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2010</study_first_posted>
  <last_update_submitted>July 14, 2011</last_update_submitted>
  <last_update_submitted_qc>July 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Hamid Gourabi, Chief</name_title>
    <organization>Royan Institute</organization>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>Embryo transfer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

